SS-31 is a mitochondria-targeted tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH₂) originally discovered by Dr. Hazel Szeto at Cornell University. It uniquely binds to cardiolipin, a phospholipid essential for mitochondrial structure and function. By stabilizing cardiolipin, SS-31 helps the mitochondria work more efficiently, protecting them from oxidative stress and improving overall energy metabolism — essentially acting as mitochondrial armor, reinforcing the cell's energy system and preventing downstream damage that contributes to aging, fatigue, and degenerative disease.  

​

It also goes by several names: Elamipretide (pharmaceutical), Bendavia (earlier trademark), MTP-131 (research), and Forzinity (FDA-approved brand).

​

Mechanism of Action

SS-31 features an alternating arrangement of basic and aromatic amino acids, which facilitates its passage through the blood–brain barrier, cell membranes, and mitochondrial membranes, with its concentration capacity on the mitochondrial inner membrane exceeding 1,000-fold compared to the surrounding environment.  

​

Unlike traditional antioxidants such as vitamin C and E that circulate throughout the body, SS-31 concentrates 5,000-fold specifically in mitochondria and prevents reactive oxygen species (ROS) from being produced in the first place by stabilizing electron transport — addressing the source rather than the symptoms of oxidative damage.  

​

Key Benefits

1. Mitochondrial Repair & Energy Production

SS-31 doesn't just protect against damage — it actively restores mitochondrial efficiency, with some effects on ATP production measurable acutely, while clinical benefits like improved exercise tolerance typically develop over weeks of treatment.  

​

2. Cardiovascular Support

SS-31 crosses the outer mitochondrial membrane and localizes to the inner membrane, where it binds to cardiolipin via electrostatic and hydrophobic interactions, showing beneficial effects on improving cardiac mitochondrial dysfunction.  

​

3. Anti-Aging & Longevity

SS-31 is considered structural repair for existing mitochondria rather than pharmacological override, with its strongest case in chronic fatigue where mitochondrial membrane damage is the bottleneck, and as a structural foundation in mitochondrial longevity stacks alongside NAD+ and MOTS-c.  

​

4. Neuroprotection

Numerous studies have confirmed the pronounced therapeutic efficacy of SS-31 in addressing systemic disorders associated with mitochondrial dysfunction, including neurological conditions.  (ScienceDirect) Its ability to cross the blood–brain barrier makes it particularly relevant for brain health and neuroprotection.

​

5. Pulmonary & Organ Protection

Experimental data show SS-31 reduces lung inflammation and fibrotic tissue remodeling, suggesting potential benefits for chronic lung disease.